Return to blog

September 21, 2016

Sequencing.com introduces first agnostic platform for genetic data

Sequencing.com on Wednesday announced its global public launch with a platform that allows users to securely store, analyze and share their DNA information. According to the company, the "world's first agnostic platform for genetic data" is compatible with data produced by almost every genetic testing technology, including DNA microarrays, whole genome sequencing and exome sequencing, such as those marketed by Illumina, Helix and 23andMe.

CEO Brandon Colby estimated that "within the next eight years, we expect that between 100 million and two billion human genomes will be sequenced." He added that the platform "provides the ability for everyone to keep their genetic data safe, while also being able to use it on a daily basis to personalise and improve their lives."

 

Continue reading Sequencing introduces first agnostic platform for genetic data

Use your DNA to live healthier, happier and longer with the Sequencing.com Membership Program.

Categories:
News
Tags:
Data
DNA App Store
rare disease genetic screening
Genetic Testing for Rare Diseases with Sequencing.com
February 5, 2019
Are you worried that you or a loved one may have a rare disease? Are you worried about a disease your future child may inherit? If you are, click to learn about genetic testing options for detecting rare diseases including what type of test may be best for your condition.
Read more
Delete 23andMe Data
How to Delete Your 23andMe Data: A Step-by-Step Guide
October 8, 2024
Learn how to delete your 23andMe data and protect your privacy with this step-by-step guide.
Read more
Genetic API Alternative After the 23andMe API Changes | DNA API
Genetic API Alternative After the 23andMe API Changes
September 12, 2018
As of Sept 6, 2018, 23andMe discontinued its genetics API (application programming interface). Because of this, app developers who solely depended upon 23andMe's API need to find an alternative API for quickly and securely importing a person's DNA data. We have the solution.
Read more